Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023
Period Ending	Sep 30, 2024	Dec 31, 2023
Cash & Equivalents	0.1	0.58
Cash & Short-Term Investments	0.1	0.58
Total Current Assets	0.12	0.58
Other Long-Term Assets	72.66	69.89
Total Assets	72.78	70.47
Accrued Expenses	0.14	0.02
Total Current Liabilities	0.23	0.02
Other Long-Term Liabilities	73.35	70.58
Total Liabilities	73.58	70.6
Common Stock	0	0
Retained Earnings	-0.8	-0.13
Shareholders' Equity	-0.8	-0.13
Total Liabilities & Equity	72.78	70.47
Net Cash (Debt)	0.1	0.58
Net Cash Per Share	0.01	0.26
Filing Date Shares Outstanding	9.03	9.03
Total Common Shares Outstanding	9.03	9.03
Working Capital	-0.11	0.56
Book Value Per Share	-0.09	-0.01
Tangible Book Value	-0.8	-0.13
Tangible Book Value Per Share	-0.09	-0.01

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q